User login
Clinicians should assess older men for risk factors for osteoporosis and measure bone density by dual-energy x-ray absorptiometry if any risk factors are present, a new guideline from the American College of Physicians recommends.
How old is “older” is left open to interpretation and is one point of difference between the ACP guideline and guidelines issued by the National Osteoporosis Foundation (NOF) in February 2008.
The new NOF guidelines include screening and treatment in men as well as women, and recommend bone density testing in men aged 50–69 who have risk factors for osteoporosis and in all men aged 70 or older (RHEUMATOLOGY NEWS, May 2008, p. 1).
The ACP guidelines (Ann. Intern. Med. 2008;148:680-4) focus specifically on screening in men and notes the appropriate age at which to start risk assessment is uncertain. The medical evidence in the literature shows that by 65, at least 6% of men have osteoporosis proved by dual-energy x-ray absorptiometry (DXA), Dr. Amir Qaseem said in an interview.
The ACP plans to issue a separate new guideline for treating osteoporosis in men in the near future, added Dr. Qaseem, lead author of the guideline and a senior medical associate for the ACP.
The main risk factors for osteoporosis in men are age older than 70, a body mass index of 25 kg/m
The new ACP guideline is based on a systematic review of evidence published in 1990–2007 conducted by the federal Agency for Healthcare Research and Quality's evidence-based practice center in Southern California.
The prevalence of osteoporosis is estimated to be 7% in white, 5% in black, and 3% in Hispanic men, Dr. Qaseem noted. Over the next 15 years the rate of osteoporosis in U.S. men is expected to increase by half, with a doubling or tripling of hip fracture rates by 2040.
The prevalence of osteoporosis in Asian American men and other ethnic groups is unknown because of a lack of data. More research is needed, the guideline states.
Clinicians should assess older men for risk factors for osteoporosis and measure bone density by dual-energy x-ray absorptiometry if any risk factors are present, a new guideline from the American College of Physicians recommends.
How old is “older” is left open to interpretation and is one point of difference between the ACP guideline and guidelines issued by the National Osteoporosis Foundation (NOF) in February 2008.
The new NOF guidelines include screening and treatment in men as well as women, and recommend bone density testing in men aged 50–69 who have risk factors for osteoporosis and in all men aged 70 or older (RHEUMATOLOGY NEWS, May 2008, p. 1).
The ACP guidelines (Ann. Intern. Med. 2008;148:680-4) focus specifically on screening in men and notes the appropriate age at which to start risk assessment is uncertain. The medical evidence in the literature shows that by 65, at least 6% of men have osteoporosis proved by dual-energy x-ray absorptiometry (DXA), Dr. Amir Qaseem said in an interview.
The ACP plans to issue a separate new guideline for treating osteoporosis in men in the near future, added Dr. Qaseem, lead author of the guideline and a senior medical associate for the ACP.
The main risk factors for osteoporosis in men are age older than 70, a body mass index of 25 kg/m
The new ACP guideline is based on a systematic review of evidence published in 1990–2007 conducted by the federal Agency for Healthcare Research and Quality's evidence-based practice center in Southern California.
The prevalence of osteoporosis is estimated to be 7% in white, 5% in black, and 3% in Hispanic men, Dr. Qaseem noted. Over the next 15 years the rate of osteoporosis in U.S. men is expected to increase by half, with a doubling or tripling of hip fracture rates by 2040.
The prevalence of osteoporosis in Asian American men and other ethnic groups is unknown because of a lack of data. More research is needed, the guideline states.
Clinicians should assess older men for risk factors for osteoporosis and measure bone density by dual-energy x-ray absorptiometry if any risk factors are present, a new guideline from the American College of Physicians recommends.
How old is “older” is left open to interpretation and is one point of difference between the ACP guideline and guidelines issued by the National Osteoporosis Foundation (NOF) in February 2008.
The new NOF guidelines include screening and treatment in men as well as women, and recommend bone density testing in men aged 50–69 who have risk factors for osteoporosis and in all men aged 70 or older (RHEUMATOLOGY NEWS, May 2008, p. 1).
The ACP guidelines (Ann. Intern. Med. 2008;148:680-4) focus specifically on screening in men and notes the appropriate age at which to start risk assessment is uncertain. The medical evidence in the literature shows that by 65, at least 6% of men have osteoporosis proved by dual-energy x-ray absorptiometry (DXA), Dr. Amir Qaseem said in an interview.
The ACP plans to issue a separate new guideline for treating osteoporosis in men in the near future, added Dr. Qaseem, lead author of the guideline and a senior medical associate for the ACP.
The main risk factors for osteoporosis in men are age older than 70, a body mass index of 25 kg/m
The new ACP guideline is based on a systematic review of evidence published in 1990–2007 conducted by the federal Agency for Healthcare Research and Quality's evidence-based practice center in Southern California.
The prevalence of osteoporosis is estimated to be 7% in white, 5% in black, and 3% in Hispanic men, Dr. Qaseem noted. Over the next 15 years the rate of osteoporosis in U.S. men is expected to increase by half, with a doubling or tripling of hip fracture rates by 2040.
The prevalence of osteoporosis in Asian American men and other ethnic groups is unknown because of a lack of data. More research is needed, the guideline states.